AG真人官方

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

For the month of July, 2025.

Commission File Number: 001-40530

GH Research PLC

(Exact name of registrant as specified in its charter)

Joshua Dawson House

Dawson Street

Dublin 2

D02 RY95

Ireland

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

---

INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K

On July 23, 2025, GH Research PLC (the “Company”) announced global pivotal program plans and further development updates. A copy of the press release is exhibited hereto as Exhibit 99.1 and a copy of the GH Research R&D Update is attached hereto as Exhibit 99.2.

The fact that this press release and GH Research R&D Update are being made available should not be deemed an admission as to the materiality of any information contained in the materials. The information contained in the press release and GH Research R&D Update are being provided as of July 23, 2025, and the Company does not undertake any obligation to update the press release or either presentation in the future or to update forward-looking statements to reflect subsequent actual results.

EXHIBIT INDEX

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

---